NCT07372547

Brief Summary

The goal of this clinical trial is to learn if voiding in a standing position in the shower, rather than sitting on a toilet, may reduce pain associated with the act of voiding, thereby facilitating micturition and decreasing both post-void residual volume and the risk of subsequent urinary retention in women that underwent benign vaginal surgeries.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
20mo left

Started Jan 2026

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress15%
Jan 2026Jan 2028

First Submitted

Initial submission to the registry

January 4, 2026

Completed
16 days until next milestone

Study Start

First participant enrolled

January 20, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 28, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2028

Last Updated

March 25, 2026

Status Verified

February 1, 2026

Enrollment Period

2 years

First QC Date

January 4, 2026

Last Update Submit

March 22, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Post-void residual volume>150 CC

    after the first void following catheter removal

    The following 7 days after surgery

Secondary Outcomes (5)

  • Success rate of voiding trial

    The following 7 days after surgery

  • Pain during micturition

    The following 7 days after surgery

  • UTI

    The following 7 days after surgery

  • Urinary retention

    The following 7 days after surgery

  • Post-void residual volume

    The following 7 days after surgery

Study Arms (2)

Voiding position - Standing in the shower

OTHER

After removal of urine catheterization, during first micturation, the patient will stand in the shower with the water on her vulvar area

Behavioral: Voiding position - Standing in the shower

Voiding position - Sitting on the toilet

OTHER

After the removal of urine catheter for the first micturation - the patient will sit on the toilet

Behavioral: Voiding position - Sitting on the toilet

Interventions

After the removal of urine catheter, for the first micturation the woman will stand in the shower with the water on her vulvar area

Voiding position - Standing in the shower

After the removal of urine catheter, for the first micturation the women will sit on the toiled

Voiding position - Sitting on the toilet

Eligibility Criteria

Age18 Years - 99 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult women (≥18 years old).
  • Undergoing benign vaginal gynecologic surgery with indwelling catheter during surgery.
  • No bladder injury during surgery.
  • Ability and willingness to consent.
  • No known neurological or urinary conditions affecting voiding.
  • No active urinary tract infection at time of catheter removal.

You may not qualify if:

  • Bladder injury during surgery.
  • Neurological disease affecting bladder function.
  • Active urinary tract infection.
  • Inability to void either standing in shower or sitting (depending on randomization).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Assuta Ashdod Hospital

Ashdod, Israel

NOT YET RECRUITING

Assuta Ashdod Medical Center

Ashdod, Israel

RECRUITING

MeSH Terms

Conditions

PainUrinary Retention

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Central Study Contacts

Elad Preuss, M.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Gynaecologist

Study Record Dates

First Submitted

January 4, 2026

First Posted

January 28, 2026

Study Start

January 20, 2026

Primary Completion (Estimated)

January 20, 2028

Study Completion (Estimated)

January 20, 2028

Last Updated

March 25, 2026

Record last verified: 2026-02

Locations